Validation pour Ingenuity308

vers la météo de la validation par utilisateur

Ingenuity308

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 93 - PMID ?

In SP kidney , subcutaneous injection of deferoxamine decreases expression of SP NODE mRNA that is increased by subcutaneous injection of ( Val5 ) NODE .

name="reponse" value="NA"> Non annotée
name="reponse" value="JSP"> Je ne sais pas
name="reponse" value="INS"> Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

<?php echo $Com ; ?>

name="reponse" value="A0">Analyse 0

       +----------------------COMP:V-N(In)---------------------+          +-------COMP:N-N(of)-------+------------------------APPOS------------------------+              
       |                             +---------SUBJ:V-N--------+          |           +-MOD_ATT:N-ADJ+              +----COMP:V_PASS-N(by)----+            |              
       |                  +MOD_ATT:N-+-COMP:N-N(of)-+          +--OBJ:V-N-+           |       +MOD_AT+              |              +MOD_ATT:N-+MOD_PO+     |              
       |                  |          |              |          |          |           |       |      |              |              |          |      |     |              
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,deferoxamine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,injection)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
APPOS (mRNA,Val5)
COMP:V_PASS-N(by) (increase,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
MOD_POST:N-ADJ (injection,of)

name="reponse" value="A1">Analyse 1

                                     +---------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+     
                                     |                         +----------------------------------------------SUBJ:V-N----------------------------------------------+     
                                     |                         +-------------COMP:N-N(of)------------+------------------------APPOS------------------------+        |     
       +--------MOD_ATT:N-ADJ--------+                         |                      +-MOD_ATT:N-ADJ+              +----COMP:V_PASS-N(by)----+            |        |     
       |                  +MOD_ATT:N-+-COMP:N-N(of)-+          |                      |       +MOD_AT+              |              +MOD_ATT:N-+MOD_PO+     |        |     
       |                  |          |              |          |                      |       |      |              |              |          |      |     |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,deferoxamine)
COMP:N-N(of) (decrease,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
APPOS (mRNA,Val5)
COMP:V_PASS-N(by) (increase,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
MOD_POST:N-ADJ (injection,of)
COMP:V-N(In) (__NODE__,injection)
SUBJ:V-N (__NODE__,decrease)

name="reponse" value="A2">Analyse 2

       +----------------------COMP:V-N(In)---------------------+          +-------COMP:N-N(of)-------+------------------------APPOS------------------------+              
       |      +------MOD_ATT:N-N-----+---------SUBJ:V-N--------+          |           +-MOD_ATT:N-ADJ+              +----COMP:V_PASS-N(by)----+            |              
       |      |           +MOD_ATT:N-+-COMP:N-N(of)-+          +--OBJ:V-N-+           |       +MOD_AT+              |              +MOD_ATT:N-+MOD_PO+     |              
       |      |           |          |              |          |          |           |       |      |              |              |          |      |     |              
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-N (injection,kidney)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,deferoxamine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,injection)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
APPOS (mRNA,Val5)
COMP:V_PASS-N(by) (increase,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
MOD_POST:N-ADJ (injection,of)

name="reponse" value="A3">Analyse 3

       +----------------------COMP:V-N(In)---------------------+                              +----------------------------APPOS---------------------------+              
       |                             +---------SUBJ:V-N--------+          +----COMP:N-N(of)---+-------OBJ:V-N-------+-------COMP:V-N(by)------+            |              
       |                  +MOD_ATT:N-+-COMP:N-N(of)-+          +--OBJ:V-N-+           +MOD_ATT+      +---SUBJ:V-N---+              +MOD_ATT:N-+MOD_PO+     |              
       |                  |          |              |          |          |           |       |      |              |              |          |      |     |              
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,deferoxamine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,injection)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,Val5)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
MOD_POST:N-ADJ (injection,of)

name="reponse" value="A4">Analyse 4

                                                                                              +----------------------------APPOS---------------------------+              
       +----------------------COMP:V-N(In)---------------------+                              +-------OBJ:V-N-------+                                      |              
       |                             +---------SUBJ:V-N--------+          +----COMP:N-N(of)---+      +---SUBJ:V-N---+-------COMP:V-N(by)------+            |              
       |                  +MOD_ATT:N-+-COMP:N-N(of)-+          +--OBJ:V-N-+           +MOD_ATT+      +SUBJ:V-N+     |              +MOD_ATT:N-+MOD_PO+     |              
       |                  |          |              |          |          |           |       |      |        |     |              |          |      |     |              
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,deferoxamine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,injection)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,Val5)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
MOD_POST:N-ADJ (injection,of)

name="reponse" value="A5">Analyse 5

                                     +---------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+     
                                     |                         +----------------------------------------------SUBJ:V-N----------------------------------------------+     
                                     |                         +-----------------------OBJ:V-N----------------------+                                               |     
                                     |                         |          +-----------------SUBJ:V-N----------------+                                               |     
                                     |                         |          +-------COMP:N-N(of)-------+              |                                               |     
       +--------MOD_ATT:N-ADJ--------+                         |          |           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+-COMP:N-N(of)-+          |          |           |       +MOD_AT+              |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,deferoxamine)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)
COMP:V-N(In) (__NODE__,injection)
SUBJ:V-N (__NODE__,decrease)

name="reponse" value="A6">Analyse 6

                                     +---------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+     
                                     |                         +----------------------------------------------SUBJ:V-N----------------------------------------------+     
                                     |                         +-----------------------OBJ:V-N----------------------+                                               |     
                                     |                         |          +-----------------SUBJ:V-N----------------+                                               |     
                                     |                         |          +-------COMP:N-N(of)-------+              |                                               |     
       +--------MOD_ATT:N-ADJ--------+                         |          |           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+-COMP:N-N(of)-+          |          |           |       +MOD_AT+SUBJ:V-N+     |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,deferoxamine)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)
COMP:V-N(In) (__NODE__,injection)
SUBJ:V-N (__NODE__,decrease)

name="reponse" value="A7">Analyse 7

                                     +---------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+     
                                     |              +--------------------------------------------------COMP:V-N(of)-------------------------------------------------+     
                                     |              |          +----------------------------------------------SUBJ:V-N----------------------------------------------+     
                                     |              |          +-------------COMP:N-N(of)------------+------------------------APPOS------------------------+        |     
       +--------MOD_ATT:N-ADJ--------+              |          |                      +-MOD_ATT:N-ADJ+              +----COMP:V_PASS-N(by)----+            |        |     
       |                  +MOD_ATT:N-+              |          |                      |       +MOD_AT+              |              +MOD_ATT:N-+MOD_PO+     |        |     
       |                  |          |              |          |                      |       |      |              |              |          |      |     |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (decrease,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
APPOS (mRNA,Val5)
COMP:V_PASS-N(by) (increase,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
MOD_POST:N-ADJ (injection,of)
COMP:V-N(In) (__NODE__,injection)
COMP:V-N(of) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,decrease)

name="reponse" value="A8">Analyse 8

                                     +---------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+     
                                     |                         +----------------------------------------------SUBJ:V-N----------------------------------------------+     
                                     |                         |                              +----------------------------APPOS---------------------------+        |     
       +--------MOD_ATT:N-ADJ--------+                         +---------COMP:N-N(of)---------+-------OBJ:V-N-------+-------COMP:V-N(by)------+            |        |     
       |                  +MOD_ATT:N-+-COMP:N-N(of)-+          |                      +MOD_ATT+      +---SUBJ:V-N---+              +MOD_ATT:N-+MOD_PO+     |        |     
       |                  |          |              |          |                      |       |      |              |              |          |      |     |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,deferoxamine)
COMP:N-N(of) (decrease,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,Val5)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
MOD_POST:N-ADJ (injection,of)
COMP:V-N(In) (__NODE__,injection)
SUBJ:V-N (__NODE__,decrease)

name="reponse" value="A9">Analyse 9

                                     +---------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+     
                                     |                         +----------------------------------------------SUBJ:V-N----------------------------------------------+     
                                     |                         |                              +----------------------------APPOS---------------------------+        |     
                                     |                         |                              +-------OBJ:V-N-------+                                      |        |     
       +--------MOD_ATT:N-ADJ--------+                         +---------COMP:N-N(of)---------+      +---SUBJ:V-N---+-------COMP:V-N(by)------+            |        |     
       |                  +MOD_ATT:N-+-COMP:N-N(of)-+          |                      +MOD_ATT+      +SUBJ:V-N+     |              +MOD_ATT:N-+MOD_PO+     |        |     
       |                  |          |              |          |                      |       |      |        |     |              |          |      |     |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,deferoxamine)
COMP:N-N(of) (decrease,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,Val5)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
MOD_POST:N-ADJ (injection,of)
COMP:V-N(In) (__NODE__,injection)
SUBJ:V-N (__NODE__,decrease)

name="reponse" value="A10">Analyse 10

                                     +---------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+     
                                     |                         +----------------------------------------------SUBJ:V-N----------------------------------------------+     
                                     |                         +-----------------------OBJ:V-N----------------------+                                               |     
                                     |                         |          +-----------------SUBJ:V-N----------------+                                               |     
                                     |                         |          +-------COMP:N-N(of)-------+              |                                               |     
       +--------MOD_ATT:N-ADJ--------+                         |          |           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+-COMP:N-N(of)-+          |          |           |       +MOD_AT+              |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,deferoxamine)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)
COMP:V-N(In) (__NODE__,injection)
SUBJ:V-N (__NODE__,decrease)

name="reponse" value="A11">Analyse 11

                                     +---------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+     
                                     |                         +----------------------------------------------SUBJ:V-N----------------------------------------------+     
                                     |                         +-----------------------OBJ:V-N----------------------+                                               |     
                                     |                         |          +-----------------SUBJ:V-N----------------+                                               |     
                                     |                         |          +--------------SUBJ:V-N-------------+     |                                               |     
                                     |                         |          +-------COMP:N-N(of)-------+        |     |                                               |     
       +--------MOD_ATT:N-ADJ--------+                         |          |           +-MOD_ATT:N-ADJ+        |     +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+-COMP:N-N(of)-+          |          |           |       +MOD_AT+        |     |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,deferoxamine)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)
COMP:V-N(In) (__NODE__,injection)
SUBJ:V-N (__NODE__,decrease)

name="reponse" value="A12">Analyse 12

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     |                                    +-----------------SUBJ:V-N----------------+                                                     
                                     |                                    +-------COMP:N-N(of)-------+              +--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+-------COMP:N-N(of)------+          |           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              +MOD_ATT:N-+          |           |       +MOD_AT+              |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,decrease)
MOD_ATT:N-N (decrease,deferoxamine)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,injection)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A13">Analyse 13

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     |                                    +-----------------SUBJ:V-N----------------+                                                     
                                     |                                    +-------COMP:N-N(of)-------+              +--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+-------COMP:N-N(of)------+          |           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              +MOD_ATT:N-+          |           |       +MOD_AT+SUBJ:V-N+     |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,decrease)
MOD_ATT:N-N (decrease,deferoxamine)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,injection)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A14">Analyse 14

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     |                                    +-----------------SUBJ:V-N----------------+                                                     
                                     |                                    +-------COMP:N-N(of)-------+              +--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+-------COMP:N-N(of)------+          |           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              +MOD_ATT:N-+          |           |       +MOD_AT+              |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,decrease)
MOD_ATT:N-N (decrease,deferoxamine)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,injection)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A15">Analyse 15

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     |                                    +-----------------SUBJ:V-N----------------+                                                     
                                     |                                    +--------------SUBJ:V-N-------------+     |                                                     
                                     |                                    +-------COMP:N-N(of)-------+        |     +--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+-------COMP:N-N(of)------+          |           +-MOD_ATT:N-ADJ+        |     +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              +MOD_ATT:N-+          |           |       +MOD_AT+        |     |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,decrease)
MOD_ATT:N-N (decrease,deferoxamine)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
COMP:V-N(In) (increase,injection)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A16">Analyse 16

       +----------------------COMP:V-N(In)---------------------+                              +----------------------------APPOS---------------------------+              
       |      +------MOD_ATT:N-N-----+---------SUBJ:V-N--------+          +----COMP:N-N(of)---+-------OBJ:V-N-------+-------COMP:V-N(by)------+            |              
       |      |           +MOD_ATT:N-+-COMP:N-N(of)-+          +--OBJ:V-N-+           +MOD_ATT+      +---SUBJ:V-N---+              +MOD_ATT:N-+MOD_PO+     |              
       |      |           |          |              |          |          |           |       |      |              |              |          |      |     |              
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-N (injection,kidney)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,deferoxamine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,injection)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,Val5)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
MOD_POST:N-ADJ (injection,of)

name="reponse" value="A17">Analyse 17

                                                                                              +----------------------------APPOS---------------------------+              
       +----------------------COMP:V-N(In)---------------------+                              +-------OBJ:V-N-------+                                      |              
       |      +------MOD_ATT:N-N-----+---------SUBJ:V-N--------+          +----COMP:N-N(of)---+      +---SUBJ:V-N---+-------COMP:V-N(by)------+            |              
       |      |           +MOD_ATT:N-+-COMP:N-N(of)-+          +--OBJ:V-N-+           +MOD_ATT+      +SUBJ:V-N+     |              +MOD_ATT:N-+MOD_PO+     |              
       |      |           |          |              |          |          |           |       |      |        |     |              |          |      |     |              
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-N (injection,kidney)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,deferoxamine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,injection)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,Val5)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
MOD_POST:N-ADJ (injection,of)

name="reponse" value="A18">Analyse 18

                                     +---------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+     
                                     |              +--------------------------------------------------COMP:V-N(of)-------------------------------------------------+     
                                     |              |          +----------------------------------------------SUBJ:V-N----------------------------------------------+     
                                     |              |          +-----------------------OBJ:V-N----------------------+                                               |     
                                     |              |          |          +-----------------SUBJ:V-N----------------+                                               |     
                                     |              |          |          +-------COMP:N-N(of)-------+              |                                               |     
       +--------MOD_ATT:N-ADJ--------+              |          |          |           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          |          |           |       +MOD_AT+              |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)
COMP:V-N(In) (__NODE__,injection)
COMP:V-N(of) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,decrease)

name="reponse" value="A19">Analyse 19

                                     +---------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+     
                                     |              +--------------------------------------------------COMP:V-N(of)-------------------------------------------------+     
                                     |              |          +----------------------------------------------SUBJ:V-N----------------------------------------------+     
                                     |              |          +-----------------------OBJ:V-N----------------------+                                               |     
                                     |              |          |          +-----------------SUBJ:V-N----------------+                                               |     
                                     |              |          |          +-------COMP:N-N(of)-------+              |                                               |     
       +--------MOD_ATT:N-ADJ--------+              |          |          |           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          |          |           |       +MOD_AT+SUBJ:V-N+     |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)
COMP:V-N(In) (__NODE__,injection)
COMP:V-N(of) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,decrease)

name="reponse" value="A20">Analyse 20

                                     +---------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+     
                                     |              +--------------------------------------------------COMP:V-N(of)-------------------------------------------------+     
                                     |              |          +----------------------------------------------SUBJ:V-N----------------------------------------------+     
                                     |              |          |                              +----------------------------APPOS---------------------------+        |     
       +--------MOD_ATT:N-ADJ--------+              |          +---------COMP:N-N(of)---------+-------OBJ:V-N-------+-------COMP:V-N(by)------+            |        |     
       |                  +MOD_ATT:N-+              |          |                      +MOD_ATT+      +---SUBJ:V-N---+              +MOD_ATT:N-+MOD_PO+     |        |     
       |                  |          |              |          |                      |       |      |              |              |          |      |     |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (decrease,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,Val5)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
MOD_POST:N-ADJ (injection,of)
COMP:V-N(In) (__NODE__,injection)
COMP:V-N(of) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,decrease)

name="reponse" value="A21">Analyse 21

                                     +---------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+     
                                     |              +--------------------------------------------------COMP:V-N(of)-------------------------------------------------+     
                                     |              |          +----------------------------------------------SUBJ:V-N----------------------------------------------+     
                                     |              |          |                              +----------------------------APPOS---------------------------+        |     
                                     |              |          |                              +-------OBJ:V-N-------+                                      |        |     
       +--------MOD_ATT:N-ADJ--------+              |          +---------COMP:N-N(of)---------+      +---SUBJ:V-N---+-------COMP:V-N(by)------+            |        |     
       |                  +MOD_ATT:N-+              |          |                      +MOD_ATT+      +SUBJ:V-N+     |              +MOD_ATT:N-+MOD_PO+     |        |     
       |                  |          |              |          |                      |       |      |        |     |              |          |      |     |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (decrease,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,Val5)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
MOD_POST:N-ADJ (injection,of)
COMP:V-N(In) (__NODE__,injection)
COMP:V-N(of) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,decrease)

name="reponse" value="A22">Analyse 22

                                     +---------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+     
                                     |              +--------------------------------------------------COMP:V-N(of)-------------------------------------------------+     
                                     |              |          +----------------------------------------------SUBJ:V-N----------------------------------------------+     
                                     |              |          +-----------------------OBJ:V-N----------------------+                                               |     
                                     |              |          |          +-----------------SUBJ:V-N----------------+                                               |     
                                     |              |          |          +-------COMP:N-N(of)-------+              |                                               |     
       +--------MOD_ATT:N-ADJ--------+              |          |          |           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          |          |           |       +MOD_AT+              |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)
COMP:V-N(In) (__NODE__,injection)
COMP:V-N(of) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,decrease)

name="reponse" value="A23">Analyse 23

                                     +---------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+     
                                     |              +--------------------------------------------------COMP:V-N(of)-------------------------------------------------+     
                                     |              |          +----------------------------------------------SUBJ:V-N----------------------------------------------+     
                                     |              |          +-----------------------OBJ:V-N----------------------+                                               |     
                                     |              |          |          +-----------------SUBJ:V-N----------------+                                               |     
                                     |              |          |          +--------------SUBJ:V-N-------------+     |                                               |     
                                     |              |          |          +-------COMP:N-N(of)-------+        |     |                                               |     
       +--------MOD_ATT:N-ADJ--------+              |          |          |           +-MOD_ATT:N-ADJ+        |     +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          |          |           |       +MOD_AT+        |     |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)
COMP:V-N(In) (__NODE__,injection)
COMP:V-N(of) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,decrease)

name="reponse" value="A24">Analyse 24

       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                     
       |                             +-----------------------------------SUBJ:V-N-----------------------------------+                                                     
       |                             +------------COMP:N-N(of)------------+-------COMP:N-N(of)-------+              +--------------------OBJ:V-N--------------------+     
       |                             |              +-----MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+           |       +MOD_AT+              |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,expression)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A25">Analyse 25

       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                     
       |                             +-----------------------------------SUBJ:V-N-----------------------------------+                                                     
       |                             +------------COMP:N-N(of)------------+-------COMP:N-N(of)-------+              +--------------------OBJ:V-N--------------------+     
       |                             |              +-----MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+           |       +MOD_AT+SUBJ:V-N+     |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,expression)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A26">Analyse 26

       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                     
       |                             +-----------------------------------SUBJ:V-N-----------------------------------+                                                     
       |                             +--------------------------COMP:N-N(of)-------------------------+              |                                                     
       |                             +------------COMP:N-N(of)------------+                          |              +--------------------OBJ:V-N--------------------+     
       |                             |              +-----MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+           |       +MOD_AT+              |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,expression)
COMP:N-N(of) (injection,mRNA)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A27">Analyse 27

       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                     
       |                             +-----------------------------------SUBJ:V-N-----------------------------------+                                                     
       |                             +--------------------------COMP:N-N(of)-------------------------+              |                                                     
       |                             +------------COMP:N-N(of)------------+                          |              +--------------------OBJ:V-N--------------------+     
       |                             |              +-----MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+           |       +MOD_AT+SUBJ:V-N+     |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,expression)
COMP:N-N(of) (injection,mRNA)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A28">Analyse 28

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     |                                    +-----------------SUBJ:V-N----------------+                                                     
                                     |                                    +-------COMP:N-N(of)-------+              +--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+                                    |           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+-COMP:N-N(of)-+          +MOD_ATT:N-+           |       +MOD_AT+              |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,deferoxamine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,injection)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A29">Analyse 29

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     |                                    +-----------------SUBJ:V-N----------------+                                                     
                                     |                                    +-------COMP:N-N(of)-------+              +--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+                                    |           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+-COMP:N-N(of)-+          +MOD_ATT:N-+           |       +MOD_AT+SUBJ:V-N+     |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,deferoxamine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,injection)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A30">Analyse 30

       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                     
       |                             +-----------------------------------SUBJ:V-N-----------------------------------+                                                     
       |                             +------------COMP:N-N(of)------------+-------COMP:N-N(of)-------+              +--------------------OBJ:V-N--------------------+     
       |                             |              +-----MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+           |       +MOD_AT+              |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,expression)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A31">Analyse 31

       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                     
       |                             +-----------------------------------SUBJ:V-N-----------------------------------+                                                     
       |                             |                                    +--------------SUBJ:V-N-------------+     |                                                     
       |                             +------------COMP:N-N(of)------------+-------COMP:N-N(of)-------+        |     +--------------------OBJ:V-N--------------------+     
       |                             |              +-----MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+        |     +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+           |       +MOD_AT+        |     |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,expression)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A32">Analyse 32

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     |                         +--------------------COMP:V-N(of)--------------------+                                                     
                                     |                         |          +-----------------SUBJ:V-N----------------+                                                     
                                     |                         |          +-------COMP:N-N(of)-------+              +--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+                         |          |           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              +MOD_ATT:N-+          |           |       +MOD_AT+              |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
MOD_ATT:N-N (decrease,deferoxamine)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,injection)
COMP:V-N(of) (increase,decrease)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A33">Analyse 33

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     |                         +--------------------COMP:V-N(of)--------------------+                                                     
                                     |                         |          +-----------------SUBJ:V-N----------------+                                                     
                                     |                         |          +-------COMP:N-N(of)-------+              +--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+                         |          |           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              +MOD_ATT:N-+          |           |       +MOD_AT+SUBJ:V-N+     |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
MOD_ATT:N-N (decrease,deferoxamine)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,injection)
COMP:V-N(of) (increase,decrease)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A34">Analyse 34

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     +------------COMP:N-N(of)------------+                                         +--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+              +-----MOD_ATT:N-N-----+                                         +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,expression)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,injection)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A35">Analyse 35

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     +------------COMP:N-N(of)------------+                                         +--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+              +-----MOD_ATT:N-N-----+                          +---SUBJ:V-N---+-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,expression)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,injection)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A36">Analyse 36

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     +------------COMP:N-N(of)------------+                                         +--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+              +-----MOD_ATT:N-N-----+----COMP:N-N(of)---+                     +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+           +MOD_ATT+      +---SUBJ:V-N---+              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,expression)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:V-N(In) (increase,injection)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A37">Analyse 37

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     +------------COMP:N-N(of)------------+                                         +--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+              +-----MOD_ATT:N-N-----+----COMP:N-N(of)---+      +---SUBJ:V-N---+-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+           +MOD_ATT+      +SUBJ:V-N+     |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,expression)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,injection)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A38">Analyse 38

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     |                                    +-----------------SUBJ:V-N----------------+                                                     
                                     |                                    +-------COMP:N-N(of)-------+              +--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+                                    |           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+-COMP:N-N(of)-+          +MOD_ATT:N-+           |       +MOD_AT+              |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,deferoxamine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,injection)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A39">Analyse 39

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     |                                    +-----------------SUBJ:V-N----------------+                                                     
                                     |                                    +--------------SUBJ:V-N-------------+     |                                                     
                                     |                                    +-------COMP:N-N(of)-------+        |     +--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+                                    |           +-MOD_ATT:N-ADJ+        |     +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+-COMP:N-N(of)-+          +MOD_ATT:N-+           |       +MOD_AT+        |     |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,deferoxamine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
COMP:V-N(In) (increase,injection)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A40">Analyse 40

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     +------------------COMP:N-N(of)------------------+                             |                                                     
                                     +------------COMP:N-N(of)------------+           |                             +--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+              +-----MOD_ATT:N-N-----+           |                             +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+           |       +MOD_AT+---SUBJ:V-N---+              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,expression)
COMP:N-N(of) (injection,__SP__)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,injection)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A41">Analyse 41

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     +------------------COMP:N-N(of)------------------+                             |                                                     
                                     +------------COMP:N-N(of)------------+           |                             +--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+              +-----MOD_ATT:N-N-----+           |              +---SUBJ:V-N---+-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+           |       +MOD_AT+SUBJ:V-N+     |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,expression)
COMP:N-N(of) (injection,__SP__)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,injection)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A42">Analyse 42

       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                     
       |                             +-----------------------------------SUBJ:V-N-----------------------------------+                                                     
       |                             +------------COMP:N-N(of)------------+-------COMP:N-N(of)-------+              +--------------------OBJ:V-N--------------------+     
       |                             |              +-----MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+           |       +MOD_AT+              |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,expression)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A43">Analyse 43

       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                     
       |                             +-----------------------------------SUBJ:V-N-----------------------------------+                                                     
       |                             +--------------------------------SUBJ:V-N--------------------------------+     |                                                     
       |                             +------------COMP:N-N(of)------------+-------COMP:N-N(of)-------+        |     +--------------------OBJ:V-N--------------------+     
       |                             |              +-----MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+        |     +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+           |       +MOD_AT+        |     |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,expression)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,injection)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A44">Analyse 44

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     +----------------------COMP:N-N(of)----------------------+                     |                                                     
                                     +------------COMP:N-N(of)------------+                   |                     +--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+              +-----MOD_ATT:N-N-----+                   |                     +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+           +MOD_ATT+      +---SUBJ:V-N---+              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,expression)
COMP:N-N(of) (injection,__NODE__)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:V-N(In) (increase,injection)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A45">Analyse 45

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     +----------------------COMP:N-N(of)----------------------+                     |                                                     
                                     +------------COMP:N-N(of)------------+                   |                     +--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+              +-----MOD_ATT:N-N-----+                   |      +---SUBJ:V-N---+-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+           +MOD_ATT+      +SUBJ:V-N+     |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,expression)
COMP:N-N(of) (injection,__NODE__)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,injection)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A46">Analyse 46

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     |                         +--------------------COMP:V-N(of)--------------------+                                                     
                                     |                         |          +-----------------SUBJ:V-N----------------+                                                     
                                     |                         |          +-------COMP:N-N(of)-------+              +--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+                         |          |           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              +MOD_ATT:N-+          |           |       +MOD_AT+              |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
MOD_ATT:N-N (decrease,deferoxamine)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,injection)
COMP:V-N(of) (increase,decrease)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A47">Analyse 47

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     |                         +--------------------COMP:V-N(of)--------------------+                                                     
                                     |                         |          +-----------------SUBJ:V-N----------------+                                                     
                                     |                         |          +--------------SUBJ:V-N-------------+     |                                                     
                                     |                         |          +-------COMP:N-N(of)-------+        |     +--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+                         |          |           +-MOD_ATT:N-ADJ+        |     +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              +MOD_ATT:N-+          |           |       +MOD_AT+        |     |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
MOD_ATT:N-N (decrease,deferoxamine)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
COMP:V-N(In) (increase,injection)
COMP:V-N(of) (increase,decrease)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A48">Analyse 48

       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                     
       |                             +-----------------------------------SUBJ:V-N-----------------------------------+                                                     
       |                             +--------------------------COMP:N-N(of)-------------------------+              |                                                     
       |                             +------------COMP:N-N(of)------------+                          |              +--------------------OBJ:V-N--------------------+     
       |                             |              +-----MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+           |       +MOD_AT+              |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,expression)
COMP:N-N(of) (injection,mRNA)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A49">Analyse 49

       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                     
       |                             +-----------------------------------SUBJ:V-N-----------------------------------+                                                     
       |                             +--------------------------------SUBJ:V-N--------------------------------+     |                                                     
       |                             +--------------------------COMP:N-N(of)-------------------------+        |     |                                                     
       |                             +------------COMP:N-N(of)------------+                          |        |     +--------------------OBJ:V-N--------------------+     
       |                             |              +-----MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+        |     +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+           |       +MOD_AT+        |     |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,expression)
COMP:N-N(of) (injection,mRNA)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,injection)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A50">Analyse 50

                                     +---------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+     
                                     |                         +----------------------------------------------SUBJ:V-N----------------------------------------------+     
                                     |                         +---------------------------------COMP:N-N(by)---------------------------------+                     |     
                                     |                         +-----------------------OBJ:V-N----------------------+                         |                     |     
                                     |                         |          +-----------------SUBJ:V-N----------------+                         |                     |     
                                     |                         |          +-------COMP:N-N(of)-------+              |                         |                     |     
       +--------MOD_ATT:N-ADJ--------+                         |          |           +-MOD_ATT:N-ADJ+              |                         |                     |     
       |                  +MOD_ATT:N-+-COMP:N-N(of)-+          |          |           |       +MOD_AT+              |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,deferoxamine)
COMP:N-N(by) (decrease,injection)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)
COMP:V-N(In) (__NODE__,injection)
SUBJ:V-N (__NODE__,decrease)

name="reponse" value="A51">Analyse 51

                                     +---------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+     
                                     |                         +----------------------------------------------SUBJ:V-N----------------------------------------------+     
                                     |                         +---------------------------------COMP:N-N(by)---------------------------------+                     |     
                                     |                         +-----------------------OBJ:V-N----------------------+                         |                     |     
                                     |                         |          +-----------------SUBJ:V-N----------------+                         |                     |     
                                     |                         |          +-------COMP:N-N(of)-------+              |                         |                     |     
       +--------MOD_ATT:N-ADJ--------+                         |          |           +-MOD_ATT:N-ADJ+              |                         |                     |     
       |                  +MOD_ATT:N-+-COMP:N-N(of)-+          |          |           |       +MOD_AT+SUBJ:V-N+     |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,deferoxamine)
COMP:N-N(by) (decrease,injection)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)
COMP:V-N(In) (__NODE__,injection)
SUBJ:V-N (__NODE__,decrease)

name="reponse" value="A52">Analyse 52

                                     +---------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+     
                                     |                         +----------------------------------------------SUBJ:V-N----------------------------------------------+     
                                     |                         +---------------------------------COMP:N-N(by)---------------------------------+                     |     
                                     |                         +-----------------------OBJ:V-N----------------------+                         |                     |     
                                     |                         |          +-----------------SUBJ:V-N----------------+                         |                     |     
                                     |                         |          +-------COMP:N-N(of)-------+              |                         |                     |     
       +--------MOD_ATT:N-ADJ--------+                         |          |           +-MOD_ATT:N-ADJ+              |                         |                     |     
       |                  +MOD_ATT:N-+-COMP:N-N(of)-+          |          |           |       +MOD_AT+              |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,deferoxamine)
COMP:N-N(by) (decrease,injection)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)
COMP:V-N(In) (__NODE__,injection)
SUBJ:V-N (__NODE__,decrease)

name="reponse" value="A53">Analyse 53

                                     +---------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+     
                                     |                         +----------------------------------------------SUBJ:V-N----------------------------------------------+     
                                     |                         +---------------------------------COMP:N-N(by)---------------------------------+                     |     
                                     |                         +-----------------------OBJ:V-N----------------------+                         |                     |     
                                     |                         |          +-----------------SUBJ:V-N----------------+                         |                     |     
                                     |                         |          +--------------SUBJ:V-N-------------+     |                         |                     |     
                                     |                         |          +-------COMP:N-N(of)-------+        |     |                         |                     |     
       +--------MOD_ATT:N-ADJ--------+                         |          |           +-MOD_ATT:N-ADJ+        |     |                         |                     |     
       |                  +MOD_ATT:N-+-COMP:N-N(of)-+          |          |           |       +MOD_AT+        |     |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,deferoxamine)
COMP:N-N(by) (decrease,injection)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)
COMP:V-N(In) (__NODE__,injection)
SUBJ:V-N (__NODE__,decrease)

name="reponse" value="A54">Analyse 54

       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                     
       |                                                                  +-----------------SUBJ:V-N----------------+                                                     
       +------------------------OBJ:V-N------------------------+          +-------COMP:N-N(of)-------+              +--------------------OBJ:V-N--------------------+     
       |      +------MOD_ATT:N-N-----+---------SUBJ:V-N--------+          |           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |      |           +MOD_ATT:N-+-COMP:N-N(of)-+          |          |           |       +MOD_AT+              |              +MOD_ATT:N-+----APPOS---+        |     
       |      |           |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-N (injection,kidney)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,deferoxamine)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,injection)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A55">Analyse 55

       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                     
       |                                                                  +-----------------SUBJ:V-N----------------+                                                     
       +------------------------OBJ:V-N------------------------+          +-------COMP:N-N(of)-------+              +--------------------OBJ:V-N--------------------+     
       |      +------MOD_ATT:N-N-----+---------SUBJ:V-N--------+          |           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |      |           +MOD_ATT:N-+-COMP:N-N(of)-+          |          |           |       +MOD_AT+SUBJ:V-N+     |              +MOD_ATT:N-+----APPOS---+        |     
       |      |           |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-N (injection,kidney)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,deferoxamine)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,injection)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A56">Analyse 56

       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                     
       +------------------------OBJ:V-N------------------------+                                                    +--------------------OBJ:V-N--------------------+     
       |      +------MOD_ATT:N-N-----+---------SUBJ:V-N--------+                      +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |      |           +MOD_ATT:N-+-COMP:N-N(of)-+          +--OBJ:V-N-+MOD_PO+    |       +MOD_AT+---SUBJ:V-N---+              +MOD_ATT:N-+----APPOS---+        |     
       |      |           |          |              |          |          |      |    |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-N (injection,kidney)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,deferoxamine)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,injection)
OBJ:V-N (decrease,expression)
MOD_POST:N-ADJ (expression,of)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A57">Analyse 57

       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                     
       +------------------------OBJ:V-N------------------------+                                                    +--------------------OBJ:V-N--------------------+     
       |      +------MOD_ATT:N-N-----+---------SUBJ:V-N--------+                      +-MOD_ATT:N-ADJ+---SUBJ:V-N---+-------COMP:V-N(by)------+                     |     
       |      |           +MOD_ATT:N-+-COMP:N-N(of)-+          +--OBJ:V-N-+MOD_PO+    |       +MOD_AT+SUBJ:V-N+     |              +MOD_ATT:N-+----APPOS---+        |     
       |      |           |          |              |          |          |      |    |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-N (injection,kidney)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,deferoxamine)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,injection)
OBJ:V-N (decrease,expression)
MOD_POST:N-ADJ (expression,of)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A58">Analyse 58

       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                     
       |                                                                  +-----------------SUBJ:V-N----------------+                                                     
       +------------------------OBJ:V-N------------------------+          +-------COMP:N-N(of)-------+              +--------------------OBJ:V-N--------------------+     
       |      +------MOD_ATT:N-N-----+---------SUBJ:V-N--------+          |           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |      |           +MOD_ATT:N-+-COMP:N-N(of)-+          |          |           |       +MOD_AT+              |              +MOD_ATT:N-+----APPOS---+        |     
       |      |           |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-N (injection,kidney)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,deferoxamine)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,injection)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A59">Analyse 59

       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                     
       |                                                                  +-----------------SUBJ:V-N----------------+                                                     
       |                                                                  +--------------SUBJ:V-N-------------+     |                                                     
       +------------------------OBJ:V-N------------------------+          +-------COMP:N-N(of)-------+        |     +--------------------OBJ:V-N--------------------+     
       |      +------MOD_ATT:N-N-----+---------SUBJ:V-N--------+          |           +-MOD_ATT:N-ADJ+        |     +-------COMP:V-N(by)------+                     |     
       |      |           +MOD_ATT:N-+-COMP:N-N(of)-+          |          |           |       +MOD_AT+        |     |              +MOD_ATT:N-+----APPOS---+        |     
       |      |           |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-N (injection,kidney)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,deferoxamine)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,injection)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A60">Analyse 60

       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                     
       |                             +-----------------------------------SUBJ:V-N-----------------------------------+                                                     
       |                             +------------COMP:N-N(of)------------+-------COMP:N-N(of)-------+              +--------------------OBJ:V-N--------------------+     
       |      +------MOD_ATT:N-N-----+              +-----MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |      |           +MOD_ATT:N-+              |          +MOD_ATT:N-+           |       +MOD_AT+              |              +MOD_ATT:N-+----APPOS---+        |     
       |      |           |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-N (injection,kidney)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,expression)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A61">Analyse 61

       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                     
       |                             +-----------------------------------SUBJ:V-N-----------------------------------+                                                     
       |                             +------------COMP:N-N(of)------------+-------COMP:N-N(of)-------+              +--------------------OBJ:V-N--------------------+     
       |      +------MOD_ATT:N-N-----+              +-----MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |      |           +MOD_ATT:N-+              |          +MOD_ATT:N-+           |       +MOD_AT+SUBJ:V-N+     |              +MOD_ATT:N-+----APPOS---+        |     
       |      |           |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-N (injection,kidney)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,expression)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A62">Analyse 62

       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                     
       |                             +-----------------------------------SUBJ:V-N-----------------------------------+                                                     
       |                             +--------------------------COMP:N-N(of)-------------------------+              |                                                     
       |                             +------------COMP:N-N(of)------------+                          |              +--------------------OBJ:V-N--------------------+     
       |      +------MOD_ATT:N-N-----+              +-----MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |      |           +MOD_ATT:N-+              |          +MOD_ATT:N-+           |       +MOD_AT+              |              +MOD_ATT:N-+----APPOS---+        |     
       |      |           |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-N (injection,kidney)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,expression)
COMP:N-N(of) (injection,mRNA)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A63">Analyse 63

       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                     
       |                             +-----------------------------------SUBJ:V-N-----------------------------------+                                                     
       |                             +--------------------------COMP:N-N(of)-------------------------+              |                                                     
       |                             +------------COMP:N-N(of)------------+                          |              +--------------------OBJ:V-N--------------------+     
       |      +------MOD_ATT:N-N-----+              +-----MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |      |           +MOD_ATT:N-+              |          +MOD_ATT:N-+           |       +MOD_AT+SUBJ:V-N+     |              +MOD_ATT:N-+----APPOS---+        |     
       |      |           |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-N (injection,kidney)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,expression)
COMP:N-N(of) (injection,mRNA)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A64">Analyse 64

       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                     
       |                             +-----------------------------------SUBJ:V-N-----------------------------------+                                                     
       |                             +------------COMP:N-N(of)------------+-------COMP:N-N(of)-------+              +--------------------OBJ:V-N--------------------+     
       |      +------MOD_ATT:N-N-----+              +-----MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |      |           +MOD_ATT:N-+              |          +MOD_ATT:N-+           |       +MOD_AT+              |              +MOD_ATT:N-+----APPOS---+        |     
       |      |           |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-N (injection,kidney)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,expression)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A65">Analyse 65

       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                     
       |                             +-----------------------------------SUBJ:V-N-----------------------------------+                                                     
       |                             |                                    +--------------SUBJ:V-N-------------+     |                                                     
       |                             +------------COMP:N-N(of)------------+-------COMP:N-N(of)-------+        |     +--------------------OBJ:V-N--------------------+     
       |      +------MOD_ATT:N-N-----+              +-----MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+        |     +-------COMP:V-N(by)------+                     |     
       |      |           +MOD_ATT:N-+              |          +MOD_ATT:N-+           |       +MOD_AT+        |     |              +MOD_ATT:N-+----APPOS---+        |     
       |      |           |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-N (injection,kidney)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,expression)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A66">Analyse 66

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     |              +--------------------------COMP:V-N(of)-------------------------+                                                     
                                     |              |                     +-----------------SUBJ:V-N----------------+                                                     
                                     |              |                     +-------COMP:N-N(of)-------+              +--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+              |                     |           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+           |       +MOD_AT+              |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,injection)
COMP:V-N(of) (increase,deferoxamine)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A67">Analyse 67

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     |              +--------------------------COMP:V-N(of)-------------------------+                                                     
                                     |              |                     +-----------------SUBJ:V-N----------------+                                                     
                                     |              |                     +-------COMP:N-N(of)-------+              +--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+              |                     |           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+           |       +MOD_AT+SUBJ:V-N+     |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,injection)
COMP:V-N(of) (increase,deferoxamine)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A68">Analyse 68

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     +------------COMP:N-N(of)------------+                                         +--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+              +-----MOD_ATT:N-N-----+           +---------COMP:V-N(of)--------+-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+           |       +MOD_AT+---SUBJ:V-N---+              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,expression)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,injection)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A69">Analyse 69

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     +------------COMP:N-N(of)------------+           +---------COMP:V-N(of)--------+--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+              +-----MOD_ATT:N-N-----+           |              +---SUBJ:V-N---+-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+           |       +MOD_AT+SUBJ:V-N+     |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,expression)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,injection)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A70">Analyse 70

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     +------------COMP:N-N(of)------------+                                         +--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+              +-----MOD_ATT:N-N-----+                   +-----COMP:V-N(of)----+-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+           +MOD_ATT+      +---SUBJ:V-N---+              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,expression)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:V-N(In) (increase,injection)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A71">Analyse 71

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     +------------COMP:N-N(of)------------+                   +-----COMP:V-N(of)----+--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+              +-----MOD_ATT:N-N-----+                   |      +---SUBJ:V-N---+-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+           +MOD_ATT+      +SUBJ:V-N+     |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,expression)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,injection)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A72">Analyse 72

       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                     
       |                             +-----------------------------------SUBJ:V-N-----------------------------------+                                                     
       |                             +------------COMP:N-N(of)------------+-------COMP:N-N(of)-------+              +--------------------OBJ:V-N--------------------+     
       |      +------MOD_ATT:N-N-----+              +-----MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |      |           +MOD_ATT:N-+              |          +MOD_ATT:N-+           |       +MOD_AT+              |              +MOD_ATT:N-+----APPOS---+        |     
       |      |           |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-N (injection,kidney)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,expression)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A73">Analyse 73

       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                     
       |                             +-----------------------------------SUBJ:V-N-----------------------------------+                                                     
       |                             +--------------------------------SUBJ:V-N--------------------------------+     |                                                     
       |                             +------------COMP:N-N(of)------------+-------COMP:N-N(of)-------+        |     +--------------------OBJ:V-N--------------------+     
       |      +------MOD_ATT:N-N-----+              +-----MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+        |     +-------COMP:V-N(by)------+                     |     
       |      |           +MOD_ATT:N-+              |          +MOD_ATT:N-+           |       +MOD_AT+        |     |              +MOD_ATT:N-+----APPOS---+        |     
       |      |           |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-N (injection,kidney)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,expression)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,injection)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A74">Analyse 74

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     |              +--------------------------COMP:V-N(of)-------------------------+                                                     
                                     |              |                     +-----------------SUBJ:V-N----------------+                                                     
                                     |              |                     +-------COMP:N-N(of)-------+              +--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+              |                     |           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+           |       +MOD_AT+              |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,injection)
COMP:V-N(of) (increase,deferoxamine)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A75">Analyse 75

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     |              +--------------------------COMP:V-N(of)-------------------------+                                                     
                                     |              |                     +-----------------SUBJ:V-N----------------+                                                     
                                     |              |                     +--------------SUBJ:V-N-------------+     |                                                     
                                     |              |                     +-------COMP:N-N(of)-------+        |     +--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+              |                     |           +-MOD_ATT:N-ADJ+        |     +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+           |       +MOD_AT+        |     |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
COMP:V-N(In) (increase,injection)
COMP:V-N(of) (increase,deferoxamine)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A76">Analyse 76

                                     +---------------------------------COMP:V-N(In)---------------------------------+--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+              +-----MOD_ATT:N-N-----+---------------COMP:V-N(of)--------------+-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,injection)
COMP:V-N(of) (increase,expression)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A77">Analyse 77

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     |                                    +---------------COMP:V-N(of)--------------+--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+              +-----MOD_ATT:N-N-----+                          +---SUBJ:V-N---+-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,injection)
COMP:V-N(of) (increase,expression)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A78">Analyse 78

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     |                                    +---------------COMP:V-N(of)--------------+--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+              +-----MOD_ATT:N-N-----+----COMP:N-N(of)---+                     +-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+           +MOD_ATT+      +---SUBJ:V-N---+              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:V-N(In) (increase,injection)
COMP:V-N(of) (increase,expression)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A79">Analyse 79

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     |                                    +---------------COMP:V-N(of)--------------+--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+              +-----MOD_ATT:N-N-----+----COMP:N-N(of)---+      +---SUBJ:V-N---+-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+           +MOD_ATT+      +SUBJ:V-N+     |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,injection)
COMP:V-N(of) (increase,expression)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A80">Analyse 80

       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                     
       |                             +-----------------------------------SUBJ:V-N-----------------------------------+                                                     
       |                             +--------------------------COMP:N-N(of)-------------------------+              |                                                     
       |                             +------------COMP:N-N(of)------------+                          |              +--------------------OBJ:V-N--------------------+     
       |      +------MOD_ATT:N-N-----+              +-----MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +-------COMP:V-N(by)------+                     |     
       |      |           +MOD_ATT:N-+              |          +MOD_ATT:N-+           |       +MOD_AT+              |              +MOD_ATT:N-+----APPOS---+        |     
       |      |           |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-N (injection,kidney)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,expression)
COMP:N-N(of) (injection,mRNA)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A81">Analyse 81

       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                     
       |                             +-----------------------------------SUBJ:V-N-----------------------------------+                                                     
       |                             +--------------------------------SUBJ:V-N--------------------------------+     |                                                     
       |                             +--------------------------COMP:N-N(of)-------------------------+        |     |                                                     
       |                             +------------COMP:N-N(of)------------+                          |        |     +--------------------OBJ:V-N--------------------+     
       |      +------MOD_ATT:N-N-----+              +-----MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+        |     +-------COMP:V-N(by)------+                     |     
       |      |           +MOD_ATT:N-+              |          +MOD_ATT:N-+           |       +MOD_AT+        |     |              +MOD_ATT:N-+----APPOS---+        |     
       |      |           |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-N (injection,kidney)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,expression)
COMP:N-N(of) (injection,mRNA)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,injection)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A82">Analyse 82

                                     +---------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+     
                                     |              +--------------------------------------------------COMP:V-N(of)-------------------------------------------------+     
                                     |              |          +----------------------------------------------SUBJ:V-N----------------------------------------------+     
                                     |              |          +---------------------------------COMP:N-N(by)---------------------------------+                     |     
                                     |              |          +-----------------------OBJ:V-N----------------------+                         |                     |     
                                     |              |          |          +-----------------SUBJ:V-N----------------+                         |                     |     
                                     |              |          |          +-------COMP:N-N(of)-------+              |                         |                     |     
       +--------MOD_ATT:N-ADJ--------+              |          |          |           +-MOD_ATT:N-ADJ+              |                         |                     |     
       |                  +MOD_ATT:N-+              |          |          |           |       +MOD_AT+              |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(by) (decrease,injection)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)
COMP:V-N(In) (__NODE__,injection)
COMP:V-N(of) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,decrease)

name="reponse" value="A83">Analyse 83

                                     +---------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+     
                                     |              +--------------------------------------------------COMP:V-N(of)-------------------------------------------------+     
                                     |              |          +----------------------------------------------SUBJ:V-N----------------------------------------------+     
                                     |              |          +---------------------------------COMP:N-N(by)---------------------------------+                     |     
                                     |              |          +-----------------------OBJ:V-N----------------------+                         |                     |     
                                     |              |          |          +-----------------SUBJ:V-N----------------+                         |                     |     
                                     |              |          |          +-------COMP:N-N(of)-------+              |                         |                     |     
       +--------MOD_ATT:N-ADJ--------+              |          |          |           +-MOD_ATT:N-ADJ+              |                         |                     |     
       |                  +MOD_ATT:N-+              |          |          |           |       +MOD_AT+SUBJ:V-N+     |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(by) (decrease,injection)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)
COMP:V-N(In) (__NODE__,injection)
COMP:V-N(of) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,decrease)

name="reponse" value="A84">Analyse 84

                                     +---------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+     
                                     |              +--------------------------------------------------COMP:V-N(of)-------------------------------------------------+     
                                     |              |          +----------------------------------------------SUBJ:V-N----------------------------------------------+     
                                     |              |          +---------------------------------COMP:N-N(by)---------------------------------+                     |     
                                     |              |          +-----------------------OBJ:V-N----------------------+                         |                     |     
                                     |              |          |          +-----------------SUBJ:V-N----------------+                         |                     |     
                                     |              |          |          +-------COMP:N-N(of)-------+              |                         |                     |     
       +--------MOD_ATT:N-ADJ--------+              |          |          |           +-MOD_ATT:N-ADJ+              |                         |                     |     
       |                  +MOD_ATT:N-+              |          |          |           |       +MOD_AT+              |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(by) (decrease,injection)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)
COMP:V-N(In) (__NODE__,injection)
COMP:V-N(of) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,decrease)

name="reponse" value="A85">Analyse 85

                                     +---------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+     
                                     |              +--------------------------------------------------COMP:V-N(of)-------------------------------------------------+     
                                     |              |          +----------------------------------------------SUBJ:V-N----------------------------------------------+     
                                     |              |          +---------------------------------COMP:N-N(by)---------------------------------+                     |     
                                     |              |          +-----------------------OBJ:V-N----------------------+                         |                     |     
                                     |              |          |          +-----------------SUBJ:V-N----------------+                         |                     |     
                                     |              |          |          +--------------SUBJ:V-N-------------+     |                         |                     |     
                                     |              |          |          +-------COMP:N-N(of)-------+        |     |                         |                     |     
       +--------MOD_ATT:N-ADJ--------+              |          |          |           +-MOD_ATT:N-ADJ+        |     |                         |                     |     
       |                  +MOD_ATT:N-+              |          |          |           |       +MOD_AT+        |     |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(by) (decrease,injection)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)
COMP:V-N(In) (__NODE__,injection)
COMP:V-N(of) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,decrease)

name="reponse" value="A86">Analyse 86

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     |                                    +---------------COMP:V-N(of)--------------+--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+              +-----MOD_ATT:N-N-----+           +---------COMP:V-N(of)--------+-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+           |       +MOD_AT+---SUBJ:V-N---+              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,injection)
COMP:V-N(of) (increase,expression)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A87">Analyse 87

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     |                                    +---------------COMP:V-N(of)--------------+                                                     
                                     |                                    |           +---------COMP:V-N(of)--------+--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+              +-----MOD_ATT:N-N-----+           |              +---SUBJ:V-N---+-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+           |       +MOD_AT+SUBJ:V-N+     |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,injection)
COMP:V-N(of) (increase,expression)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A88">Analyse 88

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     |                                    +---------------COMP:V-N(of)--------------+--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+              +-----MOD_ATT:N-N-----+                   +-----COMP:V-N(of)----+-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+           +MOD_ATT+      +---SUBJ:V-N---+              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |              |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:V-N(In) (increase,injection)
COMP:V-N(of) (increase,expression)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)

name="reponse" value="A89">Analyse 89

                                     +---------------------------------COMP:V-N(In)---------------------------------+                                                     
                                     |                                    +---------------COMP:V-N(of)--------------+                                                     
                                     |                                    |                   +-----COMP:V-N(of)----+--------------------OBJ:V-N--------------------+     
       +--------MOD_ATT:N-ADJ--------+              +-----MOD_ATT:N-N-----+                   |      +---SUBJ:V-N---+-------COMP:V-N(by)------+                     |     
       |                  +MOD_ATT:N-+              |          +MOD_ATT:N-+           +MOD_ATT+      +SUBJ:V-N+     |              +MOD_ATT:N-+----APPOS---+        |     
       |                  |          |              |          |          |           |       |      |        |     |              |          |            |        |     
 In __SP__ kidney , subcutaneous injection of deferoxamine decreases expression of __SP__ __NODE__ mRNA that is increased by subcutaneous injection of ( Val5 ) __NODE__ .
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
MOD_ATT:N-N (expression,deferoxamine)
MOD_ATT:N-N (expression,decrease)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,injection)
COMP:V-N(of) (increase,expression)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,injection)
OBJ:V-N (increase,__NODE__)
MOD_ATT:N-ADJ (injection,subcutaneous)
APPOS (injection,Val5)